Data have suggested a role for chronic Chlamydia pneumoniae infection in human atherosclerosis, however a direct causal role remains to be established. Elucidation of potential pathogenic mechanisms is critical to establishing whether C. pneumoniae actually possesses biological features consistent with a significant role in the initiation or exacerbation of this disease. Proteome analysis can be useful in elucidation of potential functions of expressed proteins, since changes in the bacterial proteome depend on growth stages, disease states or environmental conditions. Analysis of gene expression can also be determined via quantification of specific mRNA of a predetermined set of genes. A combination of transcriptomics and proteomics would provide a total picture of C. pneumoniae gene expression at any given time point. Evidence exists which localizes C. pneumoniae within cells of human atheromas. Thus, in order for C. pneumoniae to plan a causative role in atherogenesis, it would need to persist within intimal tissue for extended periods of time, thereby stimulating a chronic inflammatory response. An alteration of the normal growth cycle can be induced, in vitro, leading to the induction of a persistent form of the organism. More importantly, an alteration in gene expression patters, as well as the resulting Proteome, has been identified in the persistent forms of the bacterium. It is proposed that persistence of C. pneumoniae in cells of the developing atheroma, a microenvironment containing a multitude of host pro-inflammatory cytokines, could induce differential expression of specific bacterial proteins. Such proteins could serve as virulence factors or immunogens of C. pneumoniae. Modulated proteins of persistent C. pneumoniae in cell culture will be identified by mRNA and proteomics analysis, sequenced, expressed in an appropriate vector and specific antibodies. Such reagents could be used to probe infected cell cultures as confirmation step prior to their future use in probing human tissue specimens suspected of harboring persistent C.pneumoniae.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Exploratory/Developmental Grants (R21)
Project #
1R21AI051255-01
Application #
6454437
Study Section
Special Emphasis Panel (ZAI1-GLM-M (J1))
Program Officer
Taylor, Christopher E,
Project Start
2002-07-01
Project End
2004-06-30
Budget Start
2002-07-01
Budget End
2003-06-30
Support Year
1
Fiscal Year
2002
Total Cost
$168,000
Indirect Cost
Name
University of Louisville
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
City
Louisville
State
KY
Country
United States
Zip Code
40292
Timms, Peter; Good, David; Wan, Charles et al. (2009) Differential transcriptional responses between the interferon-gamma-induction and iron-limitation models of persistence for Chlamydia pneumoniae. J Microbiol Immunol Infect 42:27-37
Mukhopadhyay, Sanghamitra; Good, David; Miller, Richard D et al. (2006) Identification of Chlamydia pneumoniae proteins in the transition from reticulate to elementary body formation. Mol Cell Proteomics 5:2311-8
Polkinghorne, Adam; Hogan, Richard J; Vaughan, Lloyd et al. (2006) Differential expression of chlamydial signal transduction genes in normal and interferon gamma-induced persistent Chlamydophila pneumoniae infections. Microbes Infect 8:61-72
Mukhopadhyay, Sanghamitra; Miller, Richard D; Sullivan, Erin D et al. (2006) Protein expression profiles of Chlamydia pneumoniae in models of persistence versus those of heat shock stress response. Infect Immun 74:3853-63
Mukhopadhyay, Sanghamitra; Miller, Richard D; Summersgill, James T (2004) Analysis of altered protein expression patterns of Chlamydia pneumoniae by an integrated proteome-works system. J Proteome Res 3:878-83
Hogan, Richard J; Mathews, Sarah A; Mukhopadhyay, Sanghamitra et al. (2004) Chlamydial persistence: beyond the biphasic paradigm. Infect Immun 72:1843-55